EUVIMEDExplore EUVIMED
Fall-Kontroll-StudieStudienprotokollOpen access

Quantification of Urinary Exosomal Prostate-Specific Antigen for the Diagnosis of Prostate Cancer Using Clinical Laboratory–Based Techniques: Protocol for a Case-Control Study

Guorong Li iD, Yannick Tholance iD, Nora Mallouk iD, Louis Waeckel iD, Pascale Flandrin iD, Bruno Bali iD, Lionel Badet iD, Pierre Cornillon iD

JMIR Research Protocols · 2024

DOI: 10.2196/63551 ↗

At a glance

Fall-Kontroll-Studie in JMIR Research Protocols, 2024. Written by Guorong Li and 7 co-authors. Institution: Department of Urology, North Hospital, CHU Saint-Etienne, Saint-Etienne, France. Major MEDLINE topics: Prostatic Neoplasms, Prostate-Specific Antigen, Exosomes. Cited 5 times so far (Crossref); 22 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliographic detailsCiteRelated studies

Abstract (original language)

Background

Prostate cancer is the most common cancer in men and represents a major public health problem. The current method for the diagnosis or screening of prostate cancer is invasive and costly. There have been renewed and innovative studies searching for urinary biomarkers to aid in the diagnosis of prostate cancer, especially with technologies based on urinary exosomes. However, technologies based on urine exosomes usually need expensive machines such as an ultracentrifuge and they are difficult to standardize, which hinder their application in clinical laboratories. We have optimized and standardized the isolation of urinary exosomes with the precipitation method. We have found that urinary exosomal prostate-specific antigen (PSA) can be quantified by automatic Elecsys total PSA technique.

Objective

In this study, our objective is to utilize urinary exosomes from prostate cancer for the development of a test to aid in its diagnosis.

Methods

Exosomes from the prostate cancer cell line LNCaP was used to set up the technique. To analyze urine samples from patients, the methods include the collection of first-void urine using the Colli-Pee device, the isolation of urine exosomes using the optimized precipitation method, and the quantification of exosomal PSA by Elecsys total PSA.

Results

This will be a 2-year study. We will start including patients and controls in the last quarter of 2024. We expect the results to be published in the second quarter of 2027.

Conclusions

This is the first study to quantify urinary exosomal PSA using the Elecsys total PSA technique for the diagnosis of prostate cancer. This study emphasizes techniques that are suitable for implementation in clinical laboratories, which will facilitate the application of urinary exosomes to simplify and improve the diagnosis and screening of prostate cancer. International Registered Report Identifier (IRRID) PRR1-10.2196/63551

Subjects

MeSH terms (MEDLINE)

Prostatic NeoplasmsProstate-Specific AntigenExosomesHumansMaleCase-Control StudiesBiomarkers, Tumor

Author keywords

PSAdiagnosisliquid biopsyprostate cancerprostate-specific antigenurinary exosome

Substances

Prostate-Specific AntigenBiomarkers, Tumor

Authors and institutions

  • Department of Urology, North Hospital, CHU Saint-Etienne, Saint-Etienne, France.
  • Laboratory of Biochemistry, North Hospital, CHU Saint-Etienne, Saint-Etienne, France.
  • Center of Electronic Microscopy, CMES, Faculty of Medicine, University of Jean Monnet, Saint-Etienne, France.
  • Laboratory of Flow Cytometry, Immunology Laboratory, North Hospital, CHU Saint-Etienne, Saint-Etienne, France.
  • Laboratory of Molecular Biology, North Hospital, CHU Saint-Etienne, Saint-Etienne, France.
  • Department of Medical Oncology, North Hospital, CHU Saint-Etienne, Saint-Etienne, France.

ORCID profiles: Guorong Li, Yannick Tholance, Nora Mallouk, Louis Waeckel, Pascale Flandrin, Bruno Bali, Lionel Badet, Pierre Cornillon

Cite

APA

Li, G., Tholance, Y., Mallouk, N., Waeckel, L., Flandrin, P., Bali, B., Badet, L., & Cornillon, P. (2024). Quantification of Urinary Exosomal Prostate-Specific Antigen for the Diagnosis of Prostate Cancer Using Clinical Laboratory–Based Techniques: Protocol for a Case-Control Study. JMIR Research Protocols. https://doi.org/10.2196/63551

Vancouver

Li G, Tholance Y, Mallouk N, Waeckel L, Flandrin P, Bali B, et al. Quantification of Urinary Exosomal Prostate-Specific Antigen for the Diagnosis of Prostate Cancer Using Clinical Laboratory–Based Techniques: Protocol for a Case-Control Study. JMIR Research Protocols. 2024. doi:10.2196/63551

BibTeX
@article{Li2024,
  author = {Li, Guorong and Tholance, Yannick and Mallouk, Nora and Waeckel, Louis and Flandrin, Pascale and Bali, Bruno and Badet, Lionel and Cornillon, Pierre},
  title = {Quantification of Urinary Exosomal Prostate-Specific Antigen for the Diagnosis of Prostate Cancer Using Clinical Laboratory–Based Techniques: Protocol for a Case-Control Study},
  journal = {JMIR Research Protocols},
  year = {2024},
  doi = {10.2196/63551}
}
Start for free →